Aurobindo Pharma: Going strong - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

MidCapSelect
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aurobindo Pharma: Going strong

Nov 21, 2003

Aurobindo Pharma has announced its 1HFY04 results last month. The company has reported a 15% growth in topline. This coupled with an improvement in operating margins has helped Aurobindo Pharma post a 57% growth in bottomline. For 1HFY04, the company has recorded a 19% growth in net sales and a 5% growth in net profits.

Results at a glance ...
(Rs m) 2QFY03 2QFY04 Change 1HFY03 1HFY04 Change
Net Sales 3,048 3,490 14.5% 5,521 6,549 18.6%
Other Income 35 48 37.6% 67 104 56.6%
Expenditure 2,657 2,918 9.9% 4,791 5,583 16.5%
Operating Profit (EBDIT) 392 572 45.9% 729 966 32.4%
Operating Profit Margin (%) 12.9% 16.4%   13.2% 14.7%  
Interest 92 100 8.1% 220 160 -27.5%
Depreciation 43 84 93.8% 83 155 87.2%
Profit before Tax 291 436 49.7% 493 756 53.2%
Tax 86 115 33.1% 137 204 48.5%
Profit after Tax/(Loss) 205 322 56.7% 356 552 55.0%
Net profit margin (%) 6.7% 9.2%   6.5% 8.4%  
No. of Shares 47 48.4   47 48.4  
Diluted Earnings per share* 17.0 26.6   14.7 22.8  
P/E Ratio   10.8     12.6  
(* annualised)            

To Read the Full Story, Subscribe or Sign In
To Read the Full Story, Subscribe or Sign In


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Sep 23, 2020 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - SUVEN LIFESCIENCES COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS